Adaptive Biotechnologies vs Cognos Therapeutics
Adaptive Biotechnologies vs Cognos Therapeutics, compared side by side on 8 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Adaptive Biotechnologies is on 69/100 and Cognos Therapeutics on 8/100.
Where each one leads
Adaptive Biotechnologies
- our overall score: 69/100 against 8/100
Cognos Therapeutics
- agent readiness: 50/100 against 39/100
At a glance
| Measure | Adaptive Biotechnologies | Cognos Therapeutics |
|---|---|---|
| What it is | Leveraging the adaptive immune system to diagnose and treat disease. | Cognos Therapeutics is developing a novel therapeutic approach for neurodegenerative diseases. |
| Category | Biotech, HealthTech, Genomics, Drug Discovery | Biotech, MedTech, HealthTech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | services | platform | Services |
| Founded | 2009 | Not published |
| Headquarters | Seattle, United States | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | Adaptive Biotechnologies | Cognos Therapeutics |
|---|---|---|
| Total funding | $300M | Not published |
| Latest round | Series D | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Adaptive Biotechnologies | Cognos Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 69/100 | 8/100 |
| Search visibility | Not published | 10/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | D (50/100) |
| Domain ratingLink authority, 0-100 | 62/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Adaptive Biotechnologies | Cognos Therapeutics |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
| Analytics | Google Tag Manager | Not detected |
Adaptive Biotechnologies vs Cognos Therapeutics: common questions
Which is better, Adaptive Biotechnologies or Cognos Therapeutics?
On our 0-100 score Adaptive Biotechnologies rates higher (69/100 against 8/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 8 data points above: read the rows that match what you are buying for.
How do Adaptive Biotechnologies and Cognos Therapeutics compare on the numbers?
Adaptive Biotechnologies leads on our overall score (69/100 against 8/100). Cognos Therapeutics leads on agent readiness (50/100 against 39/100).
Read the full Adaptive Biotechnologies review and pricing or the Cognos Therapeutics review and pricing. You can also browse other Adaptive Biotechnologies alternatives we track.